LRMR
#3356
Larimar Therapeutics, Inc. - Common Stock
2.5 3 USD
-0.05%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-5.24%
Monthly Change
-34.11%
6 month change
-48.47%
Year Change
-39.33%
Previous Close
2.6 7
Open
2.6 6
Low
2.5 3
High
2.6 9
Financials
2020
Current report, 05 Mar 2020
Larimar Therapeutics, Inc. current report, 05 March 2020
8-K
Current report, 05 Feb 2020
Larimar Therapeutics, Inc. current report, 05 February 2020
8-K
Current report, 09 Jan 2020
Larimar Therapeutics, Inc. current report, 09 January 2020
8-K
2019
Annual report, FY2019
Larimar Therapeutics, Inc. annual report, FY2019
10-K
Current report, 17 Dec 2019
Larimar Therapeutics, Inc. current report, 17 December 2019
8-K
Current report, 06 Nov 2019
Larimar Therapeutics, Inc. current report, 06 November 2019
8-K
Quarterly report, Q3 FY2019
Larimar Therapeutics, Inc. quarterly report, Q3 FY2019
10-Q
Current report, 17 Sep 2019
Larimar Therapeutics, Inc. current report, 17 September 2019
8-K
Current report, 10 Sep 2019
Larimar Therapeutics, Inc. current report, 10 September 2019
8-K
Current report, 08 Aug 2019
Larimar Therapeutics, Inc. current report, 08 August 2019
8-K